Skip to Content
주식/증권 📈 긍정적

Here's Why You Should Retain McKesson Stock in Your Portfolio for Now

Yahoo Finance 07/02/2026 06:11:00 PM 2회
요약

McKesson's growth in specialty pharma, oncology services and tech-driven solutions is boosting earnings, but policy and execution risks remain in focus.

원문 기사 보기
관련 뉴스
Rekor Systems reports Q2 results
07/15/2026
Have steak, will travel: Texas Roadhouse tests first-party delivery
07/15/2026
Pacific Empire upsizes private placement to C$1.62M
07/15/2026
Aegis Brands appoints Sean Murphy as CEO
07/15/2026
뉴스 목록으로